Unknown

Dataset Information

0

Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology.


ABSTRACT: Ensuring that the patient's voice is routinely incorporated in all aspects of health care in oncology is essential to provide quality care. Patient reported outcomes (PROs) are standardized measures that are used to obtain the patient's perspective and are increasingly used in all aspects of health care to ensure optimal delivery of patient-centered care. The US Food and Drug Administration encourages that PROs be used in studies for label indications. There are no uniform standardized methods to use PROs nor is there consensus on which PROs are best for regulatory approval, comparative effectiveness research, toxicity assessment, health-related quality of life, or symptom monitoring. For this review, we conducted a literature search using PubMed and Google Scholar, and herein summarize the evidence related to the use of PROs in clinic care and research. Using valid, reliable, and easily interpretable PROs developed in comparable populations will provide the most useful results. Various ways that PROs can be used successfully in oncology have been exemplified in this overview to provide clinicians and researchers practical guidance.

SUBMITTER: Warsame R 

PROVIDER: S-EPMC6832764 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology.

Warsame Rahma R   D'Souza Anita A  

Mayo Clinic proceedings 20190925 11


Ensuring that the patient's voice is routinely incorporated in all aspects of health care in oncology is essential to provide quality care. Patient reported outcomes (PROs) are standardized measures that are used to obtain the patient's perspective and are increasingly used in all aspects of health care to ensure optimal delivery of patient-centered care. The US Food and Drug Administration encourages that PROs be used in studies for label indications. There are no uniform standardized methods t  ...[more]

Similar Datasets

| S-EPMC8335827 | biostudies-literature
| S-EPMC7187272 | biostudies-literature
| S-EPMC7013008 | biostudies-literature
| S-EPMC8068637 | biostudies-literature
| S-EPMC7704472 | biostudies-literature
| S-EPMC7251729 | biostudies-literature
| S-EPMC7180512 | biostudies-literature
| S-EPMC8056693 | biostudies-literature
| S-EPMC9296709 | biostudies-literature
| S-EPMC5419857 | biostudies-literature